Key Statistics
Market Cap$261.32M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.80
52W High$4.54
52W Low$0.91
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees87
Price Performance
1 Week+19.73%
3 Month+34.17%
1 Year+159.22%
FinancialsAnnual · QuiverQuant
Revenue$78.12M
Assets$499.15M
Liabilities$150.06M
Net Income$153.22M loss
About
Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze EDIT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.